Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034567
Filing Date
2024-11-12
Accepted
2024-11-12 16:25:31
Documents
62
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eton20240930_10q.htm   iXBRL 10-Q 944490
2 EXHIBIT 10.1 ex_744788.htm EX-10.1 734004
3 EXHIBIT 10.2 ex_744790.htm EX-10.2 128840
4 EXHIBIT 31.1 ex_716559.htm EX-31.1 8800
5 EXHIBIT 31.2 ex_716560.htm EX-31.2 8800
6 EXHIBIT 32.1 ex_716561.htm EX-32.1 6338
  Complete submission text file 0001437749-24-034567.txt   6372271

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eton-20240930.xsd EX-101.SCH 51339
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eton-20240930_cal.xml EX-101.CAL 36616
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20240930_def.xml EX-101.DEF 426004
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20240930_lab.xml EX-101.LAB 380891
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20240930_pre.xml EX-101.PRE 448248
65 EXTRACTED XBRL INSTANCE DOCUMENT eton20240930_10q_htm.xml XML 573238
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 241448704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)